Regeneron Pharmaceuticals, Inc.
REGN· Nasdaq
Regeneron Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · -3.16%
- Market cap
- $75.58B
- 102.95M shares
- Filings
- 1,045
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $14,342,900,000 | reported | |
| FY 2024 | 2024-12-31 | $14,202,000,000 | reported | |
| FY 2023 | 2023-12-31 | $13,117,200,000 | reported | |
| FY 2022 | 2022-12-31 | $12,172,900,000 | reported | |
| FY 2021 | 2021-12-31 | $16,071,700,000 | reported | |
| FY 2020 | 2020-12-31 | $8,497,100,000 | reported | |
| FY 2019 | 2019-12-31 | $6,557,600,000 revised | reported | |
| FY 2018 | 2018-12-31 | $5,145,600,000 revised | reported | |
| FY 2017 | 2017-12-31 | $5,872,200,000 | reported | |
| FY 2016 | 2016-12-31 | $4,860,400,000 | reported | |
| FY 2015 | 2015-12-31 | $4,103,728,000 | reported | |
| FY 2014 | 2014-12-31 | $2,819,557,000 | reported |
Regeneron Pharmaceuticals, Inc. · CIK 872589 · Engraved from SEC EDGAR
